Evidence synthesis, parameter correlation and probabilistic sensitivity analysis

Health Economics

Volumn 15, Issue 4, 2006, Pages 373-381

  Ades, A E ^a   Claxton, Karl ^b   Sculpher, Mark ^b  

^a MRC Health Services Research Collaboration   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Bayesian MCMC; Correlation; Cost effectiveness analysis; Evidence synthesis; Sensitivity analysis

Indexed keywords

ANALYTICAL PARAMETERS; ARTICLE; BAYES THEOREM; BIOMEDICAL TECHNOLOGY ASSESSMENT; CORRELATION ANALYSIS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DECISION MAKING; EVIDENCE BASED MEDICINE; MONTE CARLO METHOD; PRIORITY JOURNAL; PROBABILITY; SAMPLING; SENSITIVITY ANALYSIS; SIMULATION; STATISTICAL ANALYSIS; STATISTICAL MODEL;

BAYES THEOREM; COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; GREAT BRITAIN; HUMANS; MODELS, STATISTICAL; MONTE CARLO METHOD; UNCERTAINTY;

EID: 33646048017     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1068     Document Type: Article

References (72)

1. Briggs A. Handling uncertainty in economic evaluation and presenting the results. In Economic Evaluation in Health Care: Merging Theory with Practice, Drummond M, McGuire AJ (eds). Oxford University Press: Oxford, 2001; 172-214.
2. Hunink M, Glasziou P, Siegel J et al. Decision Making in Health and Medicine: Integrating Evidence and Values. Cambridge University Press: Cambridge, 2001.
3. Petitti DB. Meta-analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods.for Quantitative Synthesis in Medicine. Oxford University Press: New York, 2000.
4. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeill BJ. Probabilistic sensitivity analysis using Monte Carlo simulation: a practical approach. Med Decis Making 1985; 5: 157-177.
5. Critchfield GC, Willard KE. Probabilistic analysis of decision trees using Monte Carlo simulation. Med Decis Making 1986; 6: 85-92.
6. Thompson KM, Burmaster DE, Crouch EAC. Monte Carlo techniques for quantitative uncertainty analysis in public health risk assessments. Risk Anal 1992; 12: 53-63.
7. Lord J, Asante MA. Estimating uncertainty ranges for costs by the bootstrap procedure combined with probabilistic sensitivity analysis. Health Econ 1999; 8: 323-333.
8. Thompson KM, Graham JD. Going beyond the single number: using probabilistic risk assessment to improve risk management. Hum Ecol Risk Assess 1996; 2: 1008-1034.
9. Claxton K, Sculpher M, McCabe C et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ 2005; 14: 339-347.
10. Campolongo F, Saltelli A, Sorenson T, Tarantola S. Hitchhiker's guide to sensitivity analysis. In Sensitivity Analysis, Saltelli A, Chan K, Scott EM (eds). Wiley: Chichester, 2000; 15-47.
11. Smith AE, Ryan PB, Evans JS. The effect of neglecting correlations when propagating uncertainty and estimating the population distribution of risk. Risk Anal 1992; 12: 467-474.
12. Helton JC, Davis FJ. Sampling-based methods. In Sensitivity Analysis, Saltelli A, Chan K, Scott EM (eds). Wiley: Chichester, 2000; 101-154.
13. Bedford T, Cooke R. Probabilistic Risk Analysis: Foundations and Methods. Cambridge University Press: Cambridge, UK, 2001.
14. Mulrow CD. Rationale for systematic reviews. In Systematic Reviews, Chalmer I, Altman DG (eds). BMJ Publishing Group: London, 1995; 1-8.
15. van Valkengoed IGM, Morre SA, van den Brule AJC, Meijer CJLM, Bouter LM, Boeker AJP. Over-estimation of complication rates of chlamydia trachomatis screening programmes - implications for cost-effectiveness analyses. Int J Epidemiol 2004; 33: 416-425.
16. Ades AE. Commentary: evidence synthesis and evidence consistency. Int J Epidemiol 2004; 33: 426-427.
17. Felli JC, Hazen G. A Bayesian approach to sensitivity analysis. Health Econ 1999; 8: 263-268.
18. Briggs AH. A Bayesian approach to stochastic cost-effectiveness analysis. Health Econ 1999; 8: 257-261.
19. Spiegelhalter DJ, Abrams KR, Myles J. Bayesian Approaches to Clinical Trials and Health-Care Evaluation. Wiley: New York, 2004.
20. Parmigiani G, Samsa GA, Ancukiewicz M, Lipscomb J, Hasselblad V, Matchar D. Assessing uncertainty in cost-effectiveness analyses: application to a complex decision model. Med Decis Making 1997; 17: 390-401.
21. Samsa GP, Reutter RA, Parmigiani G et al. Performing cost-effectiveness analysis by integrating randomised trial data with a comprehensive decision model: application to treatment of ischemic stroke. J Clin Epidemiol 1999; 52: 259-271.
22. Fryback DG, Chinnis JO, Ulvila JW. Bayesian cost-effectiveness analysis: an example using the GUSTO trial. Med Decis Making 2001; 17: 83-97.
23. Parmigiani G. Modeling in Medical Decision Making: A Bayesian Approach. Wiley: New York, 2002.
24. Vanness DJ, Kim WR. Bayesian estimation, simulation, and uncertainty analysis: the cost-effectiveness of ganciclovir prophylaxis in liver transplantation. Health Econ 2002; 11: 551-566.
25. Cooper N, Sutton A, Abrams K, Turner D, Wailoo A. Comprehensive decision analytical modelling in economic evaluation: a Bayesian approach. Health Econ 2003; 13: 203-226.
26. Spiegelhalter DJ, Best NG. Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling. Stat Med 2003; 22: 3687-3709.
27. Spiegelhalter DJ, Thomas A, Best N, Lunn D. WinBUGS User Manual: Version 1.4. MRC Biostatistics Unit: Cambridge, UK, 2001.
28. Gilks WR, Richardson S, Spiegelhalter DJ. Markov Chain Monte Carlo in Practice. Chapman & Hall/CRC: London, 1996.
29. Hasselblad V. Meta-analysis of multi-treatment studies, Med Decis Making 1998; 18: 37-43.
30. Claxton K, Posnett J. An economic approach to clinical trial design and research priority-setting. Health Econ 1996; 5: 513-524.
31. Stinnett A, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analyses. Med Decis Making 1998; 18: S68-S80.
32. Kuntz KM, Williamson GD. Modelling in economic evaluation. In Economic Evaluation in Health Care: Merging Theory with Practice, Drummond M, McGuire AJ (eds). Oxford University Press: Oxford, 2001; 141-171.
33. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. Methods for Meta-analysis in Medical Research. Wiley: London, 2000.
34. McAlistair F, Laupacis A, Wells GA, Sackett DL. Users' guides to the medical literature. XIX Applying clinical trial results. B. Guidelines for determining whether a drug is exerting (more than) a class effect. J Am Med Assoc 1999; 282: 1371-1377.
35. Gleser LJ, Olkin I. Stochastically dependent effect sizes. In The Handbook of Research Synthesis, Cooper H, Hedges LV (eds). Russell Sage Foundation: New York, 1994; 339-355.
36. Eddy DM, Hasselblad V, Shachter R. Meta-analysis by the Confidence Profile Method. Academic Press: London, 1992.
37. Higgins JPT, Whitehead J. Borrowing strength from external trials in a meta-analysis. Stat Med 1996; 15: 2733-2749.
38. Domenici F, Parmigiani G, Wolpert RL, Hasselblad V. Meta-analysis of migraine headache treatments: combining information from heterogeneous designs. J Am Stat Assoc 1999; 94: 16-28.
39. Whitehead A. Meta-analysis of Controlled Clinical Trials. Wiley: Chichester, UK, 2002.
40. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 2002; 21: 2313-2324.
41. Ades AE. A chain of evidence with mixed comparisons: models for multi-parameter evidence synthesis and consistency of evidence. Stat Med 2003; 22: 2995-3016.
42. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004; 23: 3105-3124.
43. Bridle C, Bagnall A, Duffy S et al. A rapid and systematic review of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder. Health Technol Assess 2004; 8.
44. Wilby J, Kainth A, McDaid D et al. A rapid and systematic review of the clinical effectiveness, tolerability and cost effectiveness of newer drugs for epilepsy in adults. Health Technol Assess 2005; 9.
45. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Health Econ 1983; 13: 322-338.
46. Briggs A, Sculpher M. An introduction to Markov modelling for economic Evaluation. Pharmacoeconomics 1998; 13: 397-409.
47. Briggs AH, Ades AE, Price MJ. Probabilistic sensitivity analysis for decision trees with multiple branches: use of the Dirichlet distribution in a Bayesian framework. Med Decis Making 2003; 23: 341-350.
48. Iman RL, Conover WJ. A distribution-free approach to inducing rank correlation among input variables. Commun Stat Simulat Comput 1982; 11: 311-334.
49. Haas CN. On modelling correlated random variables in risk assessment. Risk Anal 1999; 19: 1205-1214.
50. Clemen RT, Reilly T. Correlations and copulas for decision and risk analysis. Manage Sci 1999; 45: 208-224.
51. Cario MC, Nelson BL. Modeling and Generating Random Numbers with Arbitrary Marginal Distributions and Correlation Matrix. Department of Industrial Engineering and Management Sciences, Northwestern University, Evanston, Illinois, 1997.
52. Hattis D, Burmaster D. Assessment of variability and uncertainty distributions for practical risk analysis. Risk Anal 1994; 14: 713-730.
53. Ades AE, Lu G. Correlations between parameters in risk models: estimation and propagation of uncertainty by Markov chain Monte Carlo. Risk Anal 2003; 6: 1165-1172.
54. Ferson S, Burgman MA. Correlations, dependency bounds and extinction risks. Biol Conserv 1995; 73: 101-105.
55. Thompson KM. Variability and uncertainty meet risk management and risk communication. Risk Anal 2002; 22: 647-654.
56. Eddy DM. The confidence profile method: a Bayesian method for assessing health technologies. Oper Res 1989; 37: 210-228.
57. Hasselblad V, McCrory DC. Meta-analytic tools for medical decision making: a practical guide. Med Decis Making 1995; 15: 81-96.
58. Spiegelhalter DJ, Myles JP, Jones DR, Abrams KR. Bayesian methods in health technology assessment. Health Technol Assess 1998; 4: 1-130.
59. Ades AE, Cliffe S. Markov chain Monte Carlo estimation of a multi-parameter decision model: consistency of evidence and the accurate assessment of uncertainty. Med Decis Making 2002; 22: 359-371.
60. Welton NJ, Ades AE. A model of toxoplasmosis incidence in the UK: evidence synthesis and consistency of evidence. Appl Stat 2005; 54: 385-404.
61. Spear RC, Hornberger GM. Eutrophication in peel inlet - II. Identification of critical uncertainties via generalized sensitivity analysis. Water Res 1980; 14: 43-49.
62. Woodruff TJ, Bois FY, Auslander D, Spear RC. Structure and parameterization of pharmokinetic models: their impact on model predictions. Risk Anal 1992; 12: 189-201.
63. Dakins ME, Toll JE, Small MJ, Brand KP. Risk-based environmental remediation: Bayesian Monte Carlo analysis and the expected value of sample information. Risk Anal 1996; 16: 67-79.
64. Dilks DW, Canale RP, Meier PG. Development of Bayesian Monte Carlo techniques for water quality model uncertainty. Ecol Model 1992; 62: 149-162.
65. Brand KP, Small MJ. Updating uncertainty in an integrated risk assessment: conceptual framework and methods. Risk Anal 1995; 15: 719-731.
66. Patwardhan A, Small MJ. Bayesian methods for model uncertainty analysis with application to future sea level rise. Risk Anal 1992; 12: 513-523.
67. Sohn M, Small M, Pantazidou M. Reducing uncertainty in site characterisation using Bayes Monte Carlo methods. J Environ Eng 2000; 126: 893-902.
68. Raftery AE, Givens GH, Zeh JE. Inference from a deterministic population dynamics model for Bowhead whales (with discussion). J Am Stat Assoc 1995; 90: 402-430.
69. Poole D, Givens GH, Raftery AE. A proposed stock assessment method and its application to bowhead whales, Balaena mysticetus. Fish Bull 1999; 97: 144-152.
70. Green EJ, MacFarlane DW, Valentine HT, Strawderman WE. Assessing uncertainty in a stand growth model by Bayesian synthesis. Forest Sci 1999; 45: 528-538.
71. Chessa AG, Dekker R, van Vliet B, Steyerberg EW, Habbema JDF. Correlations in uncertainty analysis for medical decision making: an application to heart-valve replacement. Med Decis Making 1999; 19: 276-286.
72. Clemen RT, Winkler RL. Limits for the precision and value of information from dependent sources. Oper Res 1985; 33: 427-442.